Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
Clinical trial NCT02981914 · COMPLETED
Trial details
- NCT number
- NCT02981914
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2020-10-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.